发明名称 MARKER GENES
摘要 Methods are disclosed for fast and accurate readout of kidney toxicity before it occurs and before it is demonstrated by histopathology examination. Ultimately this approach shall allow earlier compound selection. The twelve genes identified, namely Calbindin-D28k, KIM-1, OPN, EGF, Clusterin, VEGF, OAT-K1, Aldolase A, Aldolase B, Podocin, Alpha-2u and C4, were grouped and ultimately can be assessed in the form of a kit using PCR, a high throughput technology, in order to characterize and rank new compounds according to their anticipated general kidney toxicity. Also disclosed are methods for identifying agents useful in the treatment of kidney disease, methods for monitoring the efficacy of a treatment for kidney disease and kidney-specific vectors including the sequences of the disclosed genes, and a method for identifying a candidate gene associated with a biological process including kidney function.
申请公布号 WO2004005544(A2) 申请公布日期 2004.01.15
申请号 WO2003EP07111 申请日期 2003.07.03
申请人 NOVARTIS AG;NOVARTIS PHARMA GMBH;CHIBOUT, SALAH-DINE;GRENET, OLIVIER;IMBERT, GEORGES;KEHREN, JEANNE;STAEDTLER. FRANK;WOLFGANG, CURT, DOUGLAS 发明人 CHIBOUT, SALAH-DINE;GRENET, OLIVIER;IMBERT, GEORGES;KEHREN, JEANNE;STAEDTLER. FRANK;WOLFGANG, CURT, DOUGLAS
分类号 G01N33/53;A61K31/7088;A61K45/00;A61K48/00;A61P13/12;C12N15/09;C12Q1/68;G01N33/15;G01N33/68 主分类号 G01N33/53
代理机构 代理人
主权项
地址